| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |